These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood. al-Qudah AA J Child Neurol; 1994 Apr; 9(2):178-80. PubMed ID: 8006371 [TBL] [Abstract][Full Text] [Related]
9. The role of plasmapheresis in childhood Guillain-Barré syndrome. Epstein MA; Sladky JT Ann Neurol; 1990 Jul; 28(1):65-9. PubMed ID: 2375635 [TBL] [Abstract][Full Text] [Related]
10. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report. Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?]. Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755 [TBL] [Abstract][Full Text] [Related]
14. Childhood acute and chronic immune-mediated polyradiculoneuropathies. Rabie M; Nevo Y Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069 [TBL] [Abstract][Full Text] [Related]
15. Plasmapheresis in children with Guillain-Barré syndrome. Lamont PJ; Johnston HM; Berdoukas VA Neurology; 1991 Dec; 41(12):1928-31. PubMed ID: 1745351 [TBL] [Abstract][Full Text] [Related]
16. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients. Hughes RA; Hadden RD; Rees JH; Swan AV Brain; 1998 Apr; 121 ( Pt 4)():767-9. PubMed ID: 9577400 [No Abstract] [Full Text] [Related]
17. Prognosis in severe Guillain-Barré syndrome. Cole GF; Matthew DJ Arch Dis Child; 1987 Mar; 62(3):288-91. PubMed ID: 3566320 [TBL] [Abstract][Full Text] [Related]
18. [Plasmapheresis and high-dose immunoglobulins in the treatment of acute demyelinating polyneuropathy]. Marino A; Logi G; Roncucci P; Sodini ML; Fornaini F Minerva Anestesiol; 1993 Jun; 59(6):307-11. PubMed ID: 8414090 [TBL] [Abstract][Full Text] [Related]
19. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis]. Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922 [TBL] [Abstract][Full Text] [Related]